The Pittsburgh Technology Council’s Tech 50 Awards honors technology innovation in our region. On Thursday, November 14, 2024, we will celebrate the most successful and innovative companies in Southwestern Pennsylvania at the 28th annual Tech…
CytoAgents Newsroom
The Pittsburgh Technology Council celebrated the 25th annual Tech 50 Awards on Nov. 10, 2021 to honor the fastest growing and most innovative technology companies, service providers and CEOS in the Pittsburgh region.
September 25, 2024
CytoAgents has again been named a TECH 50 Life Sciences Finalist and Teresa Whalen has been named a CEO of the Year Finalist!
September 25, 2024
CytoAgents Receives Third Grant From National Institutes of Health to Advance Research on Cytokine Release Syndrome
CytoAgents Inc. (the Company), a clinical-stage biotechnology company, dedicated to developing a safe and effective treatment for Cytokine Release Syndrome (CRS), announced today that it has been awarded a $2 million National Institutes of Health…
October 17, 2023
CytoAgents Announces Initiation of Patient Enrollment in Phase 1b/2a Clinical Trial to Treat Cytokine Release Syndrome in CAR T-cell Therapy
PITTSBURGH–(BUSINESS WIRE)–CytoAgents, Inc., a clinical-stage biotechnology company developing a safe, effective treatment for Cytokine Release Syndrome (CRS), today announced that it has initiated recruitment and will enroll its first patient at UPMC Hillman Cancer Center,…